|
시장보고서
상품코드
2042675
지속성 휴대용 복막투석(CAPD) 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품 유형, 최종사용자, 지역별Continuous Ambulatory Peritoneal Dialysis Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, End User, and Geography |
||||||
지속성 휴대용 복막투석(CAPD) 시장은 2025년 13억 3,000만 달러에서 2034년까지 17억 6,000만 달러에 이를 것으로 예측됩니다. 이 시장은 2026-2034년 CAGR 3.1%를 나타낼 전망입니다. 시장 성장을 가속하는 주요 요인으로서는 만성 신장병 및 말기 신부전 유병률 증가, 편리성 높은 신장 케어를 필요로 하는 고령 인구 증가, 투석액 배합이나 카테터 기술 진보를 들 수 있습니다. 또한 원격의료나 원격 모니터링 기술 통합에 의해 예측 기간 중에 시장이 확대될 전망입니다.그러나, 훈련을 받은 전문가 부족이나 환자 인지도 낮음이 시장 성장 억제요인이 되고 있습니다.
인구 증가에 따라 휴대용 복막투석(CAPD)과 같은 편리한 신장 치료법에 대한 요구가 증가하고 있습니다. 세계보건기구(WHO)의 예측에 따르면, 60세 이상 인구는 2023년 11억 명에서 2030년까지 14억 명으로 증가할 것으로 예측됩니다. 유엔의 '세계 인구 고령화 보고서'에 따르면 65세 이상 인구는 전 세계적으로 증가하고 있으며, 선진국의 경우 2050년까지 그 비율이 20%에서 28%까지 상승할 것으로 예상되고 있습니다. 80세 이상 인구는 평균수명 연장과 출산율 감소를 배경으로 2020-2050년 사이 3배 증가하여 4억 2,600만 명에 이를 것으로 예측됩니다. 중국 여성의 만성콩팥병(CKD) 유병률은 18-39세에서 7.4%인 반면, 70세 이상에서는 24.2%로 증가합니다. 미국 질병예방통제센터(CDC)의 보고에 따르면, 미국에서는 65세 이상 성인의 34%가 CKD를 앓고 있는 반면, 18-44세에서는 6%에 불과한 것으로 나타났습니다. 노인들은 고혈압, 당뇨 등의 동반질환을 앓고 있는 경우가 많으며, 이는 말기신부전(ESRD)으로의 진행을 가속화하고 신체기능 저하와 허약상태에 대응하기 위해 투석을 필요로 합니다.
CAPD는 투석센터 방문을 최소화하고 독립적인 생활을 지원하는 유연한 재택 치료를 제공함으로써 이 계층에게 분명한 이점을 제공합니다. CAPD를 받는 고령 환자는 일상 생활 속에서 체액 교환을 할 수 있기 때문에 시설에서 혈액투석 스케줄에 비해 삶의 질을 유지하고 간병인의 부담을 줄일 수 있습니다. 연구에 따르면, 노화에 따른 혈관 접근 적응성 저하로 인해 복막 투석 접근법이 선호되는 것으로 알려져 있습니다. 이는 보조 PD 프로그램의 도움을 받으면 허약한 환자에서 반복적인 천자를 피하고 감염 위험을 줄일 수 있기 때문입니다. 전 세계적인 추세로 중저소득 국가들의 급속한 고령화와 시설 기반 케어에 대한 인프라가 부족한 상황에서 CAPD는 편리하고 비용 효율적인 관리법으로 각광받고 있습니다. GBD 2023의 데이터는 인구 고령화와 1990년 이후 만성콩팥병(CKD) 유병률의 조잡한 증가율(18.9%)과의 연관성을 보여주고 있습니다. 평균 수명이 연장되고 더 많은 노인이 말기 신부전(ESRD) 단계에 도달함에 따라 CAPD의 휴대성과 자가 관리 기능은 재택 중심의 신장 치료에 대한 선호도가 높아짐에 따라 노인 환자군의 장기적인 치료 순응도 및 치료 결과를 개선할 수 있습니다.
경쟁사 분석에서는 제품 포트폴리오(제품 만족도, 제품 기능, 가용성), 최근 시장 동향(인수합병, 신제품 출시 및 개선, 투자 및 자금 조달, 수상, 계약, 제휴 및 파트너십, 평가, 사업 확장), 지리적 확장에 따라 지속적 이동식 복막 투석 시장을 평가하고 분류합니다. 분류하고 있습니다. 이를 통해 의사결정을 지원하고 경쟁 구도를 더 잘 이해할 수 있습니다. 이 보고서는 세계 휴대용 복막투석(CAPD) 시장의 주요 업체들의 최근 주요 동향과 혁신에 대해 심층적으로 분석했습니다. 주요 시장 기업은 Baxter International Inc, Fresenius Medical Care AG & Co KGaA, Terumo Corp, Medtronic Plc, Medtronic Plc, JMS Co. Pvt. Ltd., Utah Medical Products Inc, Mitra Industries Pvt. Ltd, Newsol Technologies Inc.
제품별로 휴대용 복막투석(CAPD) 시장은 복막투석액, 복막투석 카테터, 복막투석 이송 세트, 기타로 분류됩니다. 복막 투석액 부문은 투석 주기마다 반복적으로 사용되는 수요, 환자 수 증가, 생체 적합성 솔루션의 발전, 전 세계 재택 투석 치료에 대한 선호도 증가로 인해 2025년 더 큰 시장 점유율을 차지할 것으로 예측됩니다.
지속적 통원형 복막투석(APD) 시장은 시설 내 투석 환경과 재택 케어 환경으로 구분됩니다. 2025년에는 시설 내 투석 환경 부문이 시장에서 더 큰 점유율을 차지할 것으로 예측됩니다. 환자 모니터링 시스템 강화, 숙련된 직원 확보, 합병증 관리 개선, 확립된 상환 프레임워크, 첨단 APD 장비에 대한 접근성, 중증 환자에서 감시하에 치료하는 것을 선호한다는 점 등이 시설 내 부문의 우위를 뒷받침하고 있습니다.
휴대용 복막투석(CAPD) 시장에서 사업을 전개하는 기업들은 다양한 유기적 및 무기적 전략을 채택하고 있습니다. 유기적 전략에는 주로 제품 출시와 승인 등이 포함됩니다. 시장에서 볼 수 있는 무기적 성장 전략으로는 인수, 제휴, 파트너십을 들 수 있습니다. 이러한 성장 전략을 통해 시장 참여자들은 사업을 확장하고, 지리적 입지를 강화하며, 전체 시장 성장에 기여할 수 있습니다. 또한, 인수 및 파트너십을 통해 고객 기반을 강화하고 제품 포트폴리오를 확장하는 데에도 기여했습니다. 휴대용 휴대용 복막투석 시장의 주요 업체들의 주요 동향은 다음과 같습니다.
2025년 6월, 프레제니우스 메디컬 케어는 개량형 5008X CAREsystem에 대한 FDA 510(k) 승인을 획득하고 일부 프레제니우스 키드니 케어 시설에 도입하기 시작했습니다. 2026년에는 고용량 혈액투석 여과 확대 및 임상 데이터 교환(CDE) 통합을 목표로 시판될 예정입니다.
2025년 2월, 박스터는 과산화물 경화 실리콘 튜브에서 PCBA 농도가 증가함에 따라 MiniCap EL 복막투석 이송세트에 대한 정정 신청을 했습니다. 환자는 치료를 계속해야 하지만, 6개월 미만의 환자에게는 백금 경화 튜브를 우선적으로 사용하는 것이 좋습니다. 의료 종사자 및 공급업체를 위한 유통 관련 지침이 발표되었습니다.
목차
제1장 주요 요약
제2장 지속성 휴대용 복막투석(CAPD) 시장 전망
제3장 경쟁 구도
제4장 지속성 휴대용 복막투석(CAPD) 시장 : 주요 업계 역학
제5장 지속성 휴대용 복막투석(CAPD) 시장 : 세계 시장 분석
제6장 지속성 휴대용 복막투석(CAPD) 시장 매출 분석 : 제품 유형별
제7장 지속성 휴대용 복막투석(CAPD) 시장 매출 분석 : 최종사용자별
제8장 지속성 휴대용 복막투석(CAPD) 시장 : 지역별 분석
제9장 지속성 휴대용 복막투석(CAPD) 시장 상황
제10장 지속성 휴대용 복막투석(CAPD) 시장 : 주요 기업 개요
제11장 기타 분석 대상 기업 리스트
제12장 부록
LSH 26.06.05The continuous ambulatory peritoneal dialysis market is projected to reach US$1.76 billion by 2034 from US$1.33 billion in 2025. The market is estimated to register a CAGR of 3.1% during 2026-2034. Major factors driving the market growth include the escalating prevalence of chronic kidney disease and end-stage renal disease, increasing aging population requiring convenient renal care, and advancements in dialysate formulations and catheter technologies. Further, integration of telehealth and remote monitoring technologies will likely boost the market during the forecast period. However, shortage of trained professionals and patient awareness are among the market deterrents.
The growing population size is amplifying the need for convenient renal care modalities such as CAPD. The World Health Organization (WHO) projects that the number of people aged 60 and older will rise from 1.1 billion in 2023 to 1.4 billion by 2030. The United Nations World Population Aging reports indicate that persons aged 65 and over will increase worldwide, with the proportion in developed countries rising from 20% to 28% by 2050. The number of people aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million, driven by longer life expectancies and declining birth rates. Among Chinese women, CKD prevalence climbs from 7.4% in those aged 18-39 to 24.2% for those over 70. This demographic shift correlates with higher CKD rates, as the CDC notes that CKD affects 34% of adults aged 65 and older in the US, compared to 6% in those aged 18-44. Older adults often present with comorbidities such as hypertension and diabetes, accelerating progression to ESRD and necessitating dialysis that accommodates reduced mobility and frailty.
CAPD offers distinct advantages for this demographic by providing flexible, home-based therapy that minimizes travel to dialysis centers and supports independence. Elderly patients on CAPD can perform exchanges during daily routines, preserving quality of life and reducing caregiver burden compared to in-center hemodialysis schedules. Studies highlight that aging-related declines in vascular access suitability make peritoneal approaches preferable, as they avoid repeated needling and lower infection risks in frail individuals when supported by assisted PD programs. Global inclinations show rapid aging in low- and middle-income countries, where infrastructure for facility-based care is strained, elevating CAPD's appeal for convenient, cost-effective management. The GBD 2023 data reinforces this, linking population aging to an 18.9% crude increase in CKD prevalence since 1990. As life expectancy rises and more seniors reach ESRD stages, CAPD's portability and self-management features align with the growing preference for home-centric renal care, enabling better long-term adherence and outcomes in an elderly patient base.
The comparative company analysis evaluates and categorizes the continuous ambulatory peritoneal dialysis market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Continuous Ambulatory Peritoneal Dialysis Market. The key market players are Baxter International Inc, Fresenius Medical Care AG & Co KGaA, Terumo Corp, Medtronic Plc, JMS Co., Ltd., Polymedicure, Advin Health Care Pvt. Ltd., Utah Medical Products Inc, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc.
In terms of product, the continuous ambulatory peritoneal dialysis market is bifurcated into peritoneal dialysis solution, peritoneal dialysis catheters, peritoneal dialysis transfer sets, and others. The peritoneal dialysis solution segment held a larger market share in 2025, owing to acceptance due to recurring usage in every dialysis cycle, increasing patient population, advancements in biocompatible solutions, and rising preference for home-based dialysis treatments globally.
The continuous ambulatory peritoneal dialysis market is categorized into in-center dialysis settings, home care settings. The in-center dialysis settings segment held a larger share of the market in 2025. Higher patient monitoring, availability of trained staff, better management of complications, established reimbursement frameworks, access to advanced APD equipment, and preference for supervised treatment in critical cases drive in-center segment dominance.
Companies operating in the continuous ambulatory peritoneal dialysis market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key continuous ambulatory peritoneal dialysis market players are listed below.
In June 2025, Fresenius Medical Care received FDA 510(k) clearance for an enhanced 5008X CAREsystem and began rollout at select Fresenius Kidney Care locations. A commercial release is planned for 2026 to expand high-volume hemodiafiltration and to integrate Clinical Data Exchange.
In February 2025, Baxter filed a correction for MiniCap EL peritoneal dialysis transfer sets due to elevated PCBA levels in peroxide-cured silicone tubing. Patients should continue therapy, with platinum-cured tubing prioritized for those under six months. Distribution guidance has been issued for healthcare providers and suppliers.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Continuous Ambulatory Peritoneal Dialysis Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.2.1 Raw Material Suppliers / Components
- 2.2.2 Manufacturers Process / Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End-User
- 2.2.5 Level of Integration
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.4.1 Threat of New Entrants
- 2.4.2 Threat of Substitutes
- 2.4.3 Bargaining Power of Buyers
- 2.4.4 Bargaining Power of Suppliers
- 2.4.5 Competitive Rivalry
- 2.5 PEST Analysis
- 2.6 Impact of Artificial Intelligence (AI)
- 2.7 Product or Technology Roadmap
- 2.8 Sustainability and ESG Trends
- 2.9 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Continuous Ambulatory Peritoneal Dialysis Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Escalating Prevalence of Chronic Kidney Disease and End-Stage Renal Disease
- 4.1.2 Increasing Aging Population Requiring Convenient Renal Care
- 4.1.3 Rising Advancements in Dialysate Formulations and Catheter Technologies
- 4.2 Market Restraints
- 4.2.1 High Risk of Peritonitis and Catheter-Related Infections
- 4.2.2 High Costs Associated with Dialysis Supplies
- 4.2.3 Shortage of Trained Professionals and Patient Awareness
- 4.3 Market Opportunities
- 4.3.1 Untapped Growth in Emerging Economies
- 4.3.2 Integration of Telehealth and Remote Monitoring Technologies
- 4.3.3 Growth in Home Care Settings and Cost Containment
- 4.4 Future Trends
- 4.4.1 AI-Driven Personalized Adherence and Predictive Analytics
- 4.4.2 Simplified User-Friendly CAPD Systems and Accessories
- 4.4.3 Growth of Hybrid Therapy Approaches
- 4.5 Impact of Drivers and Restraints
5. Continuous Ambulatory Peritoneal Dialysis Market - Global Market Analysis
- 5.1 Continuous Ambulatory Peritoneal Dialysis Market Revenue (US$ Million), 2021-2034
- 5.2 Continuous Ambulatory Peritoneal Dialysis Market Forecast and Analysis
6. Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - Product Type
- 6.1 Continuous Ambulatory Peritoneal Dialysis Market Forecasts and Analysis by Product Type
- 6.1.1 Peritoneal Dialysis Solution
- 6.1.1.1 Overview
- 6.1.1.2 Peritoneal Dialysis Solution: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 6.1.2 Peritoneal Dialysis Catheters
- 6.1.2.1 Overview
- 6.1.2.2 Peritoneal Dialysis Catheters: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 6.1.3 Peritoneal Dialysis Transfer Sets
- 6.1.3.1 Overview
- 6.1.3.2 Peritoneal Dialysis Transfer Sets: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 6.1.4 Others
- 6.1.4.1 Overview
- 6.1.4.2 Others: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 6.1.1 Peritoneal Dialysis Solution
7. Continuous Ambulatory Peritoneal Dialysis Market Revenue Analysis - End User
- 7.1 Continuous Ambulatory Peritoneal Dialysis Market Forecasts and Analysis by End User
- 7.1.1 In-Center Dialysis Settings
- 7.1.1.1 Overview
- 7.1.1.2 In-Center Dialysis Settings: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 7.1.2 Home Care Settings
- 7.1.2.1 Overview
- 7.1.2.2 Home Care Settings: Continuous Ambulatory Peritoneal Dialysis Market - Revenue, 2021-2034 (US$ Million)
- 7.1.1 In-Center Dialysis Settings
8. Continuous Ambulatory Peritoneal Dialysis Market - Geographical Analysis
- 8.1 North America
- 8.1.1 North America Continuous Ambulatory Peritoneal Dialysis Market Overview
- 8.1.2 North America: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.3 North America: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.1.3.1 Product Type
- 8.1.3.2 End User
- 8.1.4 North America: Continuous Ambulatory Peritoneal Dialysis Market Breakdown by Countries
- 8.1.4.1 United States Market
- 8.1.4.1.1 United States: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.4.1.2 United States: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.1.4.1.2.1 Product Type
- 8.1.4.1.2.2 End User
- 8.1.4.2 Canada Market
- 8.1.4.2.1 Canada: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.4.2.2 Canada: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.1.4.2.2.1 Product Type
- 8.1.4.2.2.2 End User
- 8.1.4.3 Mexico Market
- 8.1.4.3.1 Mexico: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.4.3.2 Mexico: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.1.4.3.2.1 Product Type
- 8.1.4.3.2.2 End User
- 8.1.4.1 United States Market
- 8.2 Europe
- 8.2.1 Europe Continuous Ambulatory Peritoneal Dialysis Market Overview
- 8.2.2 Europe: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.3 Europe: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.3.1 Product Type
- 8.2.3.2 End User
- 8.2.4 Europe: Continuous Ambulatory Peritoneal Dialysis Market Breakdown by Countries
- 8.2.4.1 Germany Market
- 8.2.4.1.1 Germany: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.1.2 Germany: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.1.2.1 Product Type
- 8.2.4.1.2.2 End User
- 8.2.4.2 United Kingdom Market
- 8.2.4.2.1 United Kingdom: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.2.2 United Kingdom: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.2.2.1 Product Type
- 8.2.4.2.2.2 End User
- 8.2.4.3 France Market
- 8.2.4.3.1 France: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.3.2 France: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.3.2.1 Product Type
- 8.2.4.3.2.2 End User
- 8.2.4.4 Italy Market
- 8.2.4.4.1 Italy: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.4.2 Italy: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.4.2.1 Product Type
- 8.2.4.4.2.2 End User
- 8.2.4.5 Spain Market
- 8.2.4.5.1 Spain: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.5.2 Spain: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.5.2.1 Product Type
- 8.2.4.5.2.2 End User
- 8.2.4.6 Rest of Europe Market
- 8.2.4.6.1 Rest of Europe: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.4.6.2 Rest of Europe: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.2.4.6.2.1 Product Type
- 8.2.4.6.2.2 End User
- 8.2.4.1 Germany Market
- 8.3 Asia Pacific
- 8.3.1 Asia Pacific Continuous Ambulatory Peritoneal Dialysis Market Overview
- 8.3.2 Asia Pacific: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.3 Asia Pacific: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.3.1 Product Type
- 8.3.3.2 End User
- 8.3.4 Asia Pacific: Continuous Ambulatory Peritoneal Dialysis Market Breakdown by Countries
- 8.3.4.1 China Market
- 8.3.4.1.1 China: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.1.2 China: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.1.2.1 Product Type
- 8.3.4.1.2.2 End User
- 8.3.4.2 Japan Market
- 8.3.4.2.1 Japan: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.2.2 Japan: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.2.2.1 Product Type
- 8.3.4.2.2.2 End User
- 8.3.4.3 India Market
- 8.3.4.3.1 India: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.3.2 India: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.3.2.1 Product Type
- 8.3.4.3.2.2 End User
- 8.3.4.4 Australia Market
- 8.3.4.4.1 Australia: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.4.2 Australia: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.4.2.1 Product Type
- 8.3.4.4.2.2 End User
- 8.3.4.5 South Korea Market
- 8.3.4.5.1 South Korea: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.5.2 South Korea: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.5.2.1 Product Type
- 8.3.4.5.2.2 End User
- 8.3.4.6 Rest of Asia Pacific Market
- 8.3.4.6.1 Rest of Asia Pacific: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.4.6.2 Rest of Asia Pacific: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.3.4.6.2.1 Product Type
- 8.3.4.6.2.2 End User
- 8.3.4.1 China Market
- 8.4 Middle East and Africa
- 8.4.1 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis Market Overview
- 8.4.2 Middle East and Africa: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.3 Middle East and Africa: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.4.3.1 Product Type
- 8.4.3.2 End User
- 8.4.4 Middle East and Africa: Continuous Ambulatory Peritoneal Dialysis Market Breakdown by Countries
- 8.4.4.1 Saudi Arabia Market
- 8.4.4.1.1 Saudi Arabia: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.4.1.2 Saudi Arabia: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.4.4.1.2.1 Product Type
- 8.4.4.1.2.2 End User
- 8.4.4.2 South Africa Market
- 8.4.4.2.1 South Africa: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.4.2.2 South Africa: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.4.4.2.2.1 Product Type
- 8.4.4.2.2.2 End User
- 8.4.4.3 United Arab Emirates Market
- 8.4.4.3.1 United Arab Emirates: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.4.3.2 United Arab Emirates: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.4.4.3.2.1 Product Type
- 8.4.4.3.2.2 End User
- 8.4.4.4 Rest of Middle East and Africa Market
- 8.4.4.4.1 Rest of Middle East and Africa: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.4.4.2 Rest of Middle East and Africa: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.4.4.4.2.1 Product Type
- 8.4.4.4.2.2 End User
- 8.4.4.1 Saudi Arabia Market
- 8.5 South and Central America
- 8.5.1 South and Central America Continuous Ambulatory Peritoneal Dialysis Market Overview
- 8.5.2 South and Central America: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.3 South and Central America: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.5.3.1 Product Type
- 8.5.3.2 End User
- 8.5.4 South and Central America: Continuous Ambulatory Peritoneal Dialysis Market Breakdown by Countries
- 8.5.4.1 Brazil Market
- 8.5.4.1.1 Brazil: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.4.1.2 Brazil: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.5.4.1.2.1 Product Type
- 8.5.4.1.2.2 End User
- 8.5.4.2 Argentina Market
- 8.5.4.2.1 Argentina: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.4.2.2 Argentina: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.5.4.2.2.1 Product Type
- 8.5.4.2.2.2 End User
- 8.5.4.3 Rest of South and Central America Market
- 8.5.4.3.1 Rest of South and Central America: Continuous Ambulatory Peritoneal Dialysis Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.4.3.2 Rest of South and Central America: Continuous Ambulatory Peritoneal Dialysis Market - By Segmentation
- 8.5.4.3.2.1 Product Type
- 8.5.4.3.2.2 End User
- 8.5.4.1 Brazil Market
9. Continuous Ambulatory Peritoneal Dialysis Market Industry Landscape
10. Continuous Ambulatory Peritoneal Dialysis Market - Key Company Profiles
- 10.1 Baxter International Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
- 10.2 Fresenius Medical Care AG & Co KGaA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
- 10.3 Terumo Corp
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
- 10.4 Medtronic Plc
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
- 10.5 JMS Co Ltd
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
- 10.6 Polymedicure
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
- 10.7 Advin Health Care Pvt Ltd
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
- 10.8 Utah Medical Products Inc
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
- 10.9 Mitra Industries Pvt. Ltd.
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
- 10.10 Newsol Technologies Inc.
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments
11. List of Additional Companies Analyzed
- 11.1 List of Additional Companies Analyzed
12. Appendix
- 12.1 Glossary
- 12.2 Research Methodology and Approach
- 12.2.1 Secondary Research
- 12.2.2 Primary Research
- 12.2.3 Market Estimation Approach
- 12.2.3.1... Supply Side Analysis
- 12.2.3.2... Demand Side Analysis
- 12.2.4 Research Assumptions and Limitations
- 12.2.5 Currency Conversion
- 12.3 About The Insight Partners
- 12.4 Market Intelligence Cloud
